Product information
|
Product description
|
Dosage form
|
Health product role
|
Route of administration
|
Dose
|
Frequency
|
Therapy duration
|
Indication(s)
|
| ADDERALL XR 10MG | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 1 Dosage forms | 1 every 1 Day(s) | 341 Day(s) | Attention deficit/hyperactivity disorder |
| ADDERALL XR 15MG | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 1 Dosage forms | 1 every 1 Day(s) | 341 Day(s) | Attention deficit/hyperactivity disorder |
| ADVAIR 125 | AEROSOL, METERED DOSE | Concomitant | Inhalation | | | | |
| APO-FLUOXETINE ORAL SOLUTION | SOLUTION ORAL | Concomitant | Unknown | | | | |
| APO-KETOCONAZOLE 200MG TABLETS | TABLET | Concomitant | Unknown | | | | |
| FLOVENT | NOT SPECIFIED | Concomitant | Inhalation | | | | |
| RISPERDAL | NOT SPECIFIED | Concomitant | Unknown | | | | |
| SINGULAIR | TABLET (CHEWABLE) | Concomitant | Unknown | | | | |